TEN Holdings Inc
Filed Oct 11, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Oct 11, 2024
Contents
Cover page
Show cover page
S-11 forms-1.htm
As filed with the U.S. Securities and Exchange Commission on October 11, 2024.
Registration No. 333-[●]
**UNITED STATES
SECURITIES AND EXCHANGE COMMISSION****
**Washington, D.C. 20549
FORM S-1**
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
(Exact name of registrant as specified in its charter)
| Nevada | 7370 | 99-1291725 |
|---|---|---|
| (State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
1170 Wheeler Way
Langhorne, PA 19047
1.800.909.9598
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
John M. Orobono Jr.
1170 Wheeler Way
Langhorne, PA 19047
1.800.909.9598
(Name, address, including zip code, and telephone number, including area code, of agent for service)
With a Copy to:
| Ying Li, Esq. Lisa Forcht, Esq. Hunter Taubman Fischer & Li LLC 950 Third Avenue, 19th Floor New York, NY 10022 (212) 530-2206 | David L. Ficksman, Esq. Joilene Wood, Esq. TroyGould PC 1801 Century Park East, 16th Floor Los Angeles, CA 90067 (310) 553-4441 |
|---|
Approximate date of commencement of proposed sale to the public: Promptly after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ |
|---|---|
| Non-accelerated filer ☒ | Smaller reporting company ☒ |
| Emerging growth company ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the U.S. Securities and Exchange Commission, acting pursuant to such Section 8(a), may determine.
This registration statement contains disclosure that will be circulated as two separate final prospectuses: (i) a prospectus (the “IPO Prospectus”) to be used in connection with the initial public offering by TEN Holdings, Inc. (the “Company”) of 2,500,000 shares of common stock (the “IPO Shares”), par value $0.0001 per share, of the Company, being registered for sale by the Company (the “IPO”) through the underwriters named on the cover page of this preliminary prospectus, and (ii) a prospectus (the “Resale Prospectus”) to be used in connection with the offer and potential resale by selling stockholders identified in this registration statement (the “Selling Stockholders”) of up to an aggregate of 4,400,000 shares of common stock (the “Resale Shares”), par value $0.0001 per share, of the Company, with an assumed initial public offering price of $5.00 per IPO Share, which is the midpoint of the price range set forth on the cover page of the preliminary prospectus contained herein. The disclosure to be included in the IPO Prospectus and the Resale Prospectus is contained in this registration statement, as amended to date, of which each of the IPO Prospectus and Resale Prospectus will form a part. The IPO Prospectus and the Resale Prospectus will be substantively identical in all respects, except for the following principal points:
| ● | they will contain different outside and inside front cover pages; among other things, the identification of the underwriters and related compensation for the IPO Shares will only be included in the IPO Prospectus and the Resale Shares will be listed on the outside and inside front covers of the Resale Prospectus without identification of the underwriters and related compensation information; |
| ● | they will contain different Offering summary subsections in the Prospectus Summary section relating to the offering of the IPO Shares and the Resale Shares, as applicable; such Offering summary subsection included in the IPO Prospectus will summarize the offering of the IPO Shares and such Offering summary subsection included in the Resale Prospectus will summarize the offering of the Resale Shares; |
| ● | they will contain different Use of Proceeds disclosure, with the Use of Proceeds section included in the Resale Prospectus only indicating that the Company will not receive any proceeds from the sale of the Resale Shares by the Selling Stockholders that occur pursuant to the registration statement of which the Resale Prospectus forms a part; |
| ● | the Capitalization and Dilution sections will not be included in the Resale Prospectus; |
| ● | the Selling Stockholders and Plan of Distribution sections will be included only in the Resale Prospectus; |
| ● | the Underwriting section from the IPO Prospectus will not be included in the Resale Prospectus; and |
| ● | the Legal Matters section in the Resale Prospectus will not include a reference to counsel for the underwriters. |
The Company has included in this registration statement, after the IPO Prospectus cover page, a set of alternate front and back cover pages to reflect the differences between the cover pages of the Resale Prospectus as compared to the cover pages of the IPO Prospectus.
The Selling Stockholders have represented to the Company that they will consider selling some or all of their respective Resale Shares registered pursuant to this registration statement immediately after the pricing of the IPO, as requested by the underwriters for the IPO, in order to create an orderly, liquid market for the common stock. As a result, the sales of our common stock registered in this registration statement will result in two offerings by the Company taking place concurrently or sequentially, which could affect the price and liquidity of, and demand for, our common stock. This risk and other risks are included in “Risk Factors” in each of the IPO Prospectus and the Resale Prospectus.
The information in this prospectus is not complete and may be changed. We may not sell the securities until the registration statement filed with the U.S. Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting any offer to buy these securities in any jurisdiction where such offer or sale is not permitted.
SUBJECT TO COMPLETION
PRELIMINARY PROSPECTUS DATED [●], 2024
2,500,000Shares of Common Stock
This is an initial public offering on a firm commitment basis of shares of common stock, par value $0.0001 per share, of TEN Holdings, Inc., a Nevada corporation. Prior to this offering, there has been no public market for our common stock. We expect the initial public offering price to be in the range of $4.00 to $6.00 per share.
We have reserved the symbol “XHLD” for purposes of listing our common stock on the Nasdaq Capital Market (“Nasdaq”) and plan to apply to list our common stock on Nasdaq. At this time, Nasdaq has not yet approved our application to list our common stock. The closing of this offering is conditioned upon Nasdaq’s final approval of our listing application, and there is no guarantee or assurance that our common stock will be approved for listing on Nasdaq.
We are an “emerging growth company” as that term is used in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. See “Prospectus Summary—Implications of Being an Emerging Growth Company.”
Additionally, we are, and following the completion of this offering, will continue to be, a “controlled company” as defined under Nasdaq Marketplace Rules 5615(c). V-Cube, Inc., our controlling stockholder, will be able to exercise [●]% of the aggregate voting power of our issued and outstanding shares of common stock and will be able to determine all matters requiring approval by our stockholders, immediately after the consummation of this offering, assuming the sales of 2,500,000 shares of common stock we are offering, the full exercise of the Representative’s Warrants (defined below) and the underwriters’ over-allotment option, and that the Selling Stockholders do not sell any Resale Shares upon closing of this offering. V-Cube, Inc. is a Japanese company listed on the Tokyo Stock Exchange and its chief executive officer, Naoaki Mashita, has served as our sole Director since February 2024. For further information, see “Principal Stockholders” and “Prospectus Summary—Our Relationship with Our Controlling Stockholder—V-Cube, Inc.” We intend to avail ourselves of the corporate governance exemptions afforded to a “controlled company” under the Nasdaq Marketplace Rules. As a result, you will not have the same protections afforded to stockholders of companies that are subject to all of the corporate governance requirements of Nasdaq. See “Risk Factors—Risks Relating to Our Capital Stock and Trading—We will be a ‘controlled company’ within the meaning of the Nasdaq listing rules, and will follow certain exemptions from certain corporate governance requirements that could adversely affect our public stockholders” and “Management—Controlled Company.”
Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page 11 of this prospectus.
| Per Share | Total Without Over-Allotment Option | Total With Over-Allotment Option | |||
| Initial public offering price of common stock | $ | $ | $ | ||
|---|---|---|---|---|---|
| Underwriters’ discount(1) | $ | $ | $ | ||
| Proceeds to our company before expenses(2) | $ | $ | $ |
| (1) | Represents an underwriting discount equal to 7% per share. For purposes of the calculation only, we assume 100% of the investors in this offering were introduced by the underwriters. For funds raised from investors introduced by the Company, the underwriting discount will be reduced to 4% per share. |
| (2) | In addition to the underwriting discounts listed above, we have agreed to issue, upon closing of this offering, warrants to Bancroft Capital, LLC (“Bancroft”), as representative of the several underwriters (the “Representative”) or any such other recipients as may be designated by Bancroft, exercisable for a five-year period after the commencement of sales of this offering, beginning from six months after the closing of this offering, entitling the representative to purchase 5.0% of the total number of shares of common stock sold in this offering (including any shares of common stock sold as a result of the exercise of the underwriters’ over-allotment option) at a per share price equal to 120.0% of the public offering price (the “Representative’s Warrants”). The registration statement of which this prospectus is a part also covers the Representative’s Warrants and the common stock issuable upon the exercise thereof. See “Underwriting” for additional information regarding total underwriter compensation. We have granted the underwriters an option for a period of 45 days after the closing of this offering to purchase up to an additional 15.0% of the total number of shares of common stock to be offered by us pursuant to this offering (excluding shares of common stock subject to this option), solely for the purpose of covering over-allotments, if any, at the public offering price less the underwriting discounts. If the underwriters exercise the option in full, the total underwriting discounts payable will be $[●], based on an assumed public offering price of $5.00 per share of common stock, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, and the total gross proceeds to us, before underwriting discounts and expenses, will be $[●]. |
The underwriters expect to deliver the shares of our common stock against payment in U.S. dollars in New York, New York on or about [●], 2024.
Neither the U.S. Securities and Exchange Commission nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Bancroft Capital, LLC
TABLE OF CONTENTS
| Page | |
|---|---|
| PROSPECTUS SUMMARY | 6 |
| THE OFFERING | 10 |
| RISK FACTORS | 11 |
| DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS | 28 |
| USE OF PROCEEDS | 29 |
| DIVIDEND POLICY | 30 |
| CAPITALIZATION | 31 |
| DILUTION | 32 |
| MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 33 |
| BUSINESS | 43 |
| MANAGEMENT | 55 |
| EXECUTIVE AND DIRECTOR COMPENSATION | 58 |
| PRINCIPAL STOCKHOLDERS | 59 |
| RELATED PARTY TRANSACTIONS | 60 |
| DESCRIPTION OF OUR SECURITIES | 61 |
| SHARES ELIGIBLE FOR FUTURE SALE | 63 |
| UNDERWRITING | 64 |
| LEGAL MATTERS | 70 |
| EXPERTS | 70 |
| WHERE YOU CAN FIND ADDITIONAL INFORMATION | 70 |
| INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | F-1 |
We and the underwriters have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred you. We take no responsibility for and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the common stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. We are not making an offer to sell the common stock in any jurisdiction where the offer or sale is not permitted or where the person making the offer or sale is not qualified to do so or to any person to whom it is not permitted to make such offer or sale. The information contained in this prospectus is current only as of the date on the front cover of the prospectus. Our business, financial condition, results of operations, and prospects may have changed since that date.
For Investors Outside the United States: The underwriters are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted. Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our common stock and the distribution of this prospectus outside the United States.
ABOUT THIS PROSPECTUS
Certain Definitions
Unless otherwise indicated or the context requires otherwise, references in this prospectus to:
| ● | “AI” are to artificial intelligence; |
| ● | “common stock” are to our shares of common stock, par value $0.0001 per share; |
| ● | “Exchange Act” are to the Securities Exchange Act of 1934, as amended; |
| ● | “preferred stock” are to our shares of preferred stock, par value $0.0001 per share, none of which are issued and outstanding; |
| ● | “SEC” are to the United States Securities and Exchange Commission; |
| ● | “Securities Act” are to the Securities Act of 1933, as amended; |
| ● | “U.S.”, “US” or “United States” are to United States of America, its territories, its possessions and all areas subject to its jurisdiction; |
| ● | “U.S. dollars,” “$,” and “dollars” are to the legal currency of the United States; and |
| ● | “we,” “us,” “our,” “our Company,” or the “Company” are to TEN Holdings, Inc. and its subsidiary, TEN Events, Inc. |
TRADEMARKS
This prospectus contains references to our trademark and service marks and to those belonging to other entities. Solely for convenience, trademarks, and trade names referred to in this prospectus may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies’ trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.